Shares of Transcat, Inc. (NASDAQ:TRNS) have been assigned a consensus broker rating score of 1.50 (Buy) from the two brokers that cover the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a buy recommendation and one has given a strong buy recommendation to the company.

Brokerages have set a 1 year consensus price target of $28.17 for the company and are predicting that the company will post $0.26 EPS for the current quarter, according to Zacks. Zacks has also given Transcat an industry rank of 235 out of 255 based on the ratings given to its competitors.

TRNS has been the topic of several recent analyst reports. Zacks Investment Research upgraded Transcat from a “hold” rating to a “buy” rating and set a $24.00 price objective on the stock in a report on Thursday, January 17th. ValuEngine upgraded Transcat from a “hold” rating to a “buy” rating in a report on Monday, February 4th.

Shares of NASDAQ:TRNS traded up $0.25 during trading on Thursday, hitting $24.20. 18,160 shares of the company’s stock traded hands, compared to its average volume of 22,736. Transcat has a 52 week low of $16.18 and a 52 week high of $25.35. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.16 and a quick ratio of 1.45. The stock has a market capitalization of $171.21 million, a PE ratio of 34.08, a price-to-earnings-growth ratio of 2.92 and a beta of 0.92.

Transcat (NASDAQ:TRNS) last released its quarterly earnings data on Monday, February 4th. The scientific and technical instruments company reported $0.21 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.26 by ($0.05). Transcat had a net margin of 4.37% and a return on equity of 12.05%. The business had revenue of $40.87 million for the quarter, compared to the consensus estimate of $43.30 million. On average, research analysts expect that Transcat will post 0.86 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Dimensional Fund Advisors LP lifted its stake in Transcat by 7.8% in the 3rd quarter. Dimensional Fund Advisors LP now owns 356,019 shares of the scientific and technical instruments company’s stock valued at $8,135,000 after acquiring an additional 25,818 shares in the last quarter. Vanguard Group Inc lifted its stake in Transcat by 1.6% in the 3rd quarter. Vanguard Group Inc now owns 253,133 shares of the scientific and technical instruments company’s stock valued at $5,785,000 after acquiring an additional 3,945 shares in the last quarter. Vanguard Group Inc. lifted its stake in Transcat by 1.6% in the 3rd quarter. Vanguard Group Inc. now owns 253,133 shares of the scientific and technical instruments company’s stock valued at $5,785,000 after acquiring an additional 3,945 shares in the last quarter. Dalton Greiner Hartman Maher & Co. lifted its stake in Transcat by 8.4% in the 1st quarter. Dalton Greiner Hartman Maher & Co. now owns 249,323 shares of the scientific and technical instruments company’s stock valued at $5,729,000 after acquiring an additional 19,292 shares in the last quarter. Finally, Thomson Horstmann & Bryant Inc. lifted its stake in Transcat by 4.2% in the 4th quarter. Thomson Horstmann & Bryant Inc. now owns 244,806 shares of the scientific and technical instruments company’s stock valued at $4,656,000 after acquiring an additional 9,762 shares in the last quarter. Hedge funds and other institutional investors own 59.65% of the company’s stock.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

See Also: Why is the conference call important?

Get a free copy of the Zacks research report on Transcat (TRNS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.